# A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

> **NCT01173601** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 1416 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** LY2216684
- **DRUG:** Placebo
- **DRUG:** SSRI

## Key facts

- **NCT ID:** NCT01173601
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 1416 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173601, "A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01173601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*